BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20027103)

  • 21. [Lithium-associated psoriasis].
    Dorevitch A; Cohen-Adad G; Jabotinsky-Rubin K; Durst R
    Harefuah; 1994 Oct; 127(7-8):228-9, 287. PubMed ID: 7813946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug reactions during heatwaves.
    Prescrire Int; 2007 Feb; 16(87):19. PubMed ID: 17326279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetopathy probably associated to self-medication with a blocker of the renin-angiotensin system.
    Esposito F; Galfetti M; Lava SA; Balestra B; Bianchetti MG
    Arch Gynecol Obstet; 2011 Nov; 284(5):1321. PubMed ID: 21792547
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cough induced by losartan with resolution after substitution with enalapril.
    Dashti-Khavidaki S; Faghihi T; Ahmadi F; Khalili H
    Clin Ther; 2008 Mar; 30(3):548-51. PubMed ID: 18405793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Losartan and hypertensive children. Another option for a small number of children.
    Prescrire Int; 2010 Aug; 19(108):160. PubMed ID: 20939445
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug induced psoriasis.
    Milavec-Puretić V; Mance M; Ceović R; Lipozenčić J
    Acta Dermatovenerol Croat; 2011; 19(1):39-42. PubMed ID: 21489366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Utilizing progress in modern antihypertensive therapy. Treating hypertension effectively from the beginning].
    MMW Fortschr Med; 2005 May; 147(19):48. PubMed ID: 15940938
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug induced alopecia].
    van den Bemt PM; Brodie-Meijer CC; Krijnen RM; Nieboer C
    Ned Tijdschr Geneeskd; 1999 May; 143(19):990-4. PubMed ID: 10368719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Optimizing antihypertensive therapy. In 5 years 35,000 strokes are preventable].
    MMW Fortschr Med; 2004 Jul; 146(27-28):52. PubMed ID: 15526671
    [No Abstract]   [Full Text] [Related]  

  • 34. [A suitable antihypertensive drug of significance. Protection of heart, brain and kidney is decisive].
    MMW Fortschr Med; 2005 May; 147(19):49. PubMed ID: 15940939
    [No Abstract]   [Full Text] [Related]  

  • 35. [AT1 receptor antagonist lorsartan and organ protection. Managing hypertension a different way].
    MMW Fortschr Med; 2006 Mar; 148(13):48-9. PubMed ID: 16642707
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute renal failure during lisinopril and losartan therapy for proteinuria.
    Hanevold CD
    Pharmacotherapy; 2006 Sep; 26(9):1348-51. PubMed ID: 16945058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension.
    Díez J
    Clin Ther; 2006 Jun; 28(6):832-48. PubMed ID: 16860167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
    Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
    Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medications as asthma triggers.
    Covar RA; Macomber BA; Szefler SJ
    Immunol Allergy Clin North Am; 2005 Feb; 25(1):169-90. PubMed ID: 15579370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.